28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Clades of Adeno-associated viruses are widely disseminated in human tissues.

      Journal of Biology

      Animals, Computational Biology, DNA, Viral, analysis, Dependovirus, classification, genetics, Genetic Therapy, methods, Genetic Vectors, Humans, Mice, Mice, Nude, Molecular Sequence Data, Parvoviridae Infections, epidemiology, virology, Primates, Recombination, Genetic, Sequence Analysis, DNA, Serotyping, alpha 1-Antitrypsin

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The potential for using Adeno-associated virus (AAV) as a vector for human gene therapy has stimulated interest in the Dependovirus genus. Serologic data suggest that AAV infections are prevalent in humans, although analyses of viruses and viral sequences from clinical samples are extremely limited. Molecular techniques were used in this study to successfully detect endogenous AAV sequences in 18% of all human tissues screened, with the liver and bone marrow being the most predominant sites. Sequence characterization of rescued AAV DNAs indicated a diverse array of molecular forms which segregate into clades whose members share functional and serologic similarities. One of the most predominant human clades is a hybrid of two previously described AAV serotypes, while another clade was found in humans and several species of nonhuman primates, suggesting a cross-species transmission of this virus. These data provide important information regarding the biology of parvoviruses in humans and their use as gene therapy vectors.

          Related collections

          Author and article information

          Journal
          15163731
          416542
          10.1128/JVI.78.12.6381-6388.2004

          Comments

          Comment on this article